POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Researchers find gene variant protective against severe COVID-19

Christian Fernsby |
An international team of researchers has discovered a specific gene variant that protects against severe COVID-19 infections.

Article continues below




Researchers at the Karolinska Institutet in Sweden, the Lady Davis Institute of the Jewish General Hospital in Canada and the VA Boston Healthcare System in the U.S. studied gene datasets collected from people of different ancestries which they say "highlights the importance of conducting clinical trials that include people of diverse descents."

Published in the journal Nature Genetics, the study analyzed 2,787 hospitalized COVID-19 patients of African ancestry and 130,997 people in a control group from six cohort studies.

Eighty percent of the individuals of African ancestry carried the protective variant, the study suggested, and later compared it with a previous study of individuals of European heritage.

“The fact that individuals of African descent had the same protection allowed us to identify the unique variant in the DNA that actually protects from COVID-19 infection," said one of the researchers at the VA Boston Healthcare System, Jennifer Huffman, who is also the first author of the study.

The protective gene variant (rs10774671-G) determines the length of the protein encoded by the gene OAS1, according to the researchers. Prior studies have shown that the longer variant of the protein is more effective against severe COVID-19.

“This study shows how important it is to include individuals of different ancestries. If we had only studied one group, we would not have been successful in identifying the gene variant in this case,” said Hugo Zeberg, one of the authors of the study and an assistant professor at the Department of Neuroscience at Karolinska Institutet.

According to the senior researcher and geneticist Brent Richards from McGill University in Canada, this study is "key to developing new drugs against COVID-19."